News & Updates
Filter by Specialty:
Novel drug STRIDES in the right direction for knee OA
21 Jun 2023
byAudrey Abella
In the phase III STRIDES X-Ray Extension study, additional doses of the investigational CLK/DYRK inhibitor lorecivivint delivered favourable outcomes for individuals with advanced knee osteoarthritis (OA).
Novel drug STRIDES in the right direction for knee OA
21 Jun 2023AI predicts early-stage rheumatoid arthritis using MRI scans
20 Jun 2023
byStephen Padilla
It is now possible to predict rheumatoid arthritis (RA), thanks to interpretations of magnetic resonance imaging (MRI) scans made by an artificial intelligence (AI) model.
AI predicts early-stage rheumatoid arthritis using MRI scans
20 Jun 2023Add-on mRNA cancer vaccine delivers promise for melanoma
20 Jun 2023
byAudrey Abella
Adding mRNA-4157, an investigational personalized neoantigen cancer vaccine, to the immune checkpoint inhibitor (ICI) pembrolizumab significantly improved recurrence-free survival (RFS) in individuals with resected high-risk melanoma, findings from the phase IIb KEYNOTE 942 study suggest.